| FDA Approves New CAR-T Therapy for Adults With Acute Leukemia | About 40% of acute lymphoblastic leukemia patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three months. |
|
|
| Cancer Health Conference Coverage | News from the American Society for Radiation Oncology annual meeting, ASCO Quality Care Symposium, ESMO Congress, ASCO Annual Meeting and more. |
|
|
| News About COVID-19 | See all our coverage of COVID-19, including how it affects people living with cancer. For more news about SARS-CoV-2, visit our sister site, COVIDHealth.com. |
|
|